{"rows":[{"id":5983,"title":"Preparing the body for psilocybin therapy: receptive and generative interoception in cancer patients","authors":"Back Anthony L., Price Cynthia J., McGregor Bonnie A., Markell Andrew","journal":"Frontiers in Psychiatry","publication_date":"2026-10-08","publication_year":2026,"doi":"10.3389/fpsyt.2026.1890966","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.3389/fpsyt.2026.1890966","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Emotional Processing,Clinical Trial,Cancer Patients","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-10-09 01:20:15","last_checked":"2026-10-09 01:20:15","bibtex":null,"source_record_id":"DOI:10.3389/fpsyt.2026.1890966","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3389/fpsyt.2026.1890966","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.3389/fpsyt.2026.1890966","source_url":"https://doi.org/10.3389/fpsyt.2026.1890966","doi":"10.3389/fpsyt.2026.1890966","pmid":"","publication_date":"2026-10-08","importer_version":"2.1.3","text_redistributed":false}},{"id":5976,"title":"An Open-Label Multidose Psilocybin Intervention for Obsessive-Compulsive Disorder.","authors":"Tiwari, P.; Nayak, S. M.; Sepeda, N. D.; Ehrenkranz, R.; Levine, M. A.; Rohde, J. S.; Miller, E.; Beritela, C. M.; Scott, J. V.; Nestadt, G.; Barrett, F. S.; Yaden, D. B.","journal":"medRxiv","publication_date":"2026-10-05","publication_year":2026,"doi":"10.64898/2026.10.01.26364511","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.10.01.26364511","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,OCD,Consciousness,Mystical Experience,Clinical Trial,Healthcare Workers,Safety","study_type":"Clinical Trial","source_name":"medRxiv","publication_status":"preprint","date_added":"2026-10-06 01:20:24","last_checked":"2026-10-09 01:20:46","bibtex":null,"source_record_id":"DOI:10.64898/2026.10.01.26364511","abstract_available":true,"abstract_source":"medRxiv","abstract_source_url":"https://doi.org/10.64898/2026.10.01.26364511","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"medRxiv","source_record_id":"DOI:10.64898/2026.10.01.26364511","source_url":"https://doi.org/10.64898/2026.10.01.26364511","doi":"10.64898/2026.10.01.26364511","pmid":"","publication_date":"2026-10-05","importer_version":"2.1.3","text_redistributed":false}},{"id":5975,"title":"Study participant perceptions of the relevance of therapist and study team personal psychedelic experience","authors":"Benjamin R. Lewis, Eric L. Garland, Zach Schwartz, Yitong Xin, Kevin Byrne, Kious Brent","journal":"Psychedelics","publication_date":"2026-10-03","publication_year":2026,"doi":"10.1016/j.psyche.2026.100041","pubmed_id":null,"openalex_id":"https://openalex.org/W7218519509","source_url":"https://doi.org/10.1016/j.psyche.2026.100041","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Spirituality,Randomized Controlled Trial,Healthcare Workers","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-10-05 01:20:20","last_checked":"2026-10-09 01:20:19","bibtex":null,"source_record_id":"DOI:10.1016/j.psyche.2026.100041","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1016/j.psyche.2026.100041","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.psyche.2026.100041","source_url":"https://doi.org/10.1016/j.psyche.2026.100041","doi":"10.1016/j.psyche.2026.100041","pmid":"","publication_date":"2026-10-03","importer_version":"2.1.3","text_redistributed":false}},{"id":5961,"title":"Worsening of Depression and Anxiety With Psilocybin: A Case Report in Cyclothymia.","authors":"Ghaemi SN.","journal":"The Journal of clinical psychiatry","publication_date":"2026-09-30","publication_year":2026,"doi":"10.4088/jcp.26cr16608","pubmed_id":"42814595","openalex_id":"https://openalex.org/W7214730919","source_url":"https://doi.org/10.4088/jcp.26cr16608","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Case Report","study_type":"Case Report","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-30 01:20:19","last_checked":"2026-10-07 01:20:21","bibtex":null,"source_record_id":"PMID:42814595","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42814595","source_url":"https://doi.org/10.4088/jcp.26cr16608","doi":"10.4088/jcp.26cr16608","pmid":"42814595","publication_date":"2026-09-30","importer_version":"2.1.3","text_redistributed":false}},{"id":5958,"title":"Age moderates the relationship between psychedelic use and mental health in naturalistic settings","authors":"Giammarco Di Gregorio, Basset Sophia, Harjot Manmohan, Warren C. Nixon, Amrutha Pogaku, Jing Zhou, David J. Sanderson, Michael L. Lengieza, Marco Bocchio","journal":"Scientific Reports","publication_date":"2026-09-24","publication_year":2026,"doi":"10.1038/s41598-026-68283-2","pubmed_id":null,"openalex_id":"https://openalex.org/W7204099123","source_url":"https://doi.org/10.1038/s41598-026-68283-2","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Chronic Pain,Aging,Longevity,Mystical Experience,Clinical Trial,Observational Study,Older Adults,Safety,Toxicity","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-09-26 01:20:21","last_checked":"2026-10-01 01:20:28","bibtex":null,"source_record_id":"DOI:10.1038/s41598-026-68283-2","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1038/s41598-026-68283-2","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1038/s41598-026-68283-2","source_url":"https://doi.org/10.1038/s41598-026-68283-2","doi":"10.1038/s41598-026-68283-2","pmid":"","publication_date":"2026-09-24","importer_version":"2.1.3","text_redistributed":false}},{"id":5956,"title":"Preclinical Anxiolytic- and Antidepressant-like Effects of α,α-Trehalose, a Bioactive Compound Identified in Psilocybe cubensis","authors":"Aylín R. Tabal-Robles, María Eva González-Trujano, Gabriel Fernando Moreno-Pérez, Alberto Hernández-León, Susana Rojas-Lima, David Martı́nez-Vargas, Hiram Luna-Munguía, Raúl Iván Escamilla-Orozco, Laura Guzmán-Dávalos, José Guadalupe Alvarado-Rodríguez, Jesús Martín Torres-Valencia","journal":"Molecules","publication_date":"2026-09-23","publication_year":2026,"doi":"10.3390/molecules31193383","pubmed_id":null,"openalex_id":"https://openalex.org/W7214086238","source_url":"https://doi.org/10.3390/molecules31193383","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Anxiety,Pharmacology,Receptor Pharmacology,Animal Study,In Vitro Study,Toxicity","study_type":"Animal Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-09-25 01:20:21","last_checked":"2026-09-30 01:20:24","bibtex":null,"source_record_id":"DOI:10.3390/molecules31193383","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3390/molecules31193383","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.3390/molecules31193383","source_url":"https://doi.org/10.3390/molecules31193383","doi":"10.3390/molecules31193383","pmid":"","publication_date":"2026-09-23","importer_version":"2.1.3","text_redistributed":false}},{"id":5952,"title":"Curious about Psilocybin? Prevalence and correlates of interest among adults with chronic pain.","authors":"Crawford CML, Walsh Z, Louw WF, Holtzman S.","journal":"Authorea Preprints","publication_date":"2026-09-21","publication_year":2026,"doi":"10.22541/authorea.15009173/v1","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.22541/authorea.15009173/v1","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Chronic Pain,Aging,Wellbeing,Observational Study","study_type":"Observational Study","source_name":"Europe PMC","publication_status":"preprint","date_added":"2026-09-23 01:20:25","last_checked":"2026-09-28 01:20:25","bibtex":null,"source_record_id":"DOI:10.22541/authorea.15009173/v1","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.22541/authorea.15009173/v1","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"DOI:10.22541/authorea.15009173/v1","source_url":"https://doi.org/10.22541/authorea.15009173/v1","doi":"10.22541/authorea.15009173/v1","pmid":"","publication_date":"2026-09-21","importer_version":"2.1.3","text_redistributed":false}},{"id":5950,"title":"Exploring the Therapeutic Potential of Psilocybin: A Comprehensive Review of Clinical Trial Evidence and Implications for Rescheduling.","authors":"Abolhasani F, Rezaiezadeh H, Langarizadeh MA, Tavakoli MR, Ilaghi M, Zare P, Ravari FK, Alamdar F, Banazadeh M, Shabani M.","journal":"Mini reviews in medicinal chemistry","publication_date":"2026-09-18","publication_year":2026,"doi":"10.2174/0113895575443239260828094859","pubmed_id":"42770437","openalex_id":"https://openalex.org/W7213987315","source_url":"https://doi.org/10.2174/0113895575443239260828094859","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,Headache / Migraine,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Wellbeing,Emotional Processing,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-23 01:20:07","last_checked":"2026-09-25 01:20:21","bibtex":null,"source_record_id":"PMID:42770437","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.2174/0113895575443239260828094859","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42770437","source_url":"https://doi.org/10.2174/0113895575443239260828094859","doi":"10.2174/0113895575443239260828094859","pmid":"42770437","publication_date":"2026-09-18","importer_version":"2.1.3","text_redistributed":false}},{"id":5945,"title":"Targeting the serotonin 1B receptor for the treatment of depression and anxiety.","authors":"Fleury S, Nautiyal KM.","journal":"Expert opinion on therapeutic targets","publication_date":"2026-09-28","publication_year":2026,"doi":"10.1080/14728222.2026.2738183","pubmed_id":"42766349","openalex_id":"https://openalex.org/W7213928055","source_url":"https://doi.org/10.1080/14728222.2026.2738183","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,End-of-Life Distress,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Biomarkers,Clinical Trial,Animal Study,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-22 01:20:05","last_checked":"2026-10-05 01:20:16","bibtex":null,"source_record_id":"PMID:42766349","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1080/14728222.2026.2738183","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42766349","source_url":"https://doi.org/10.1080/14728222.2026.2738183","doi":"10.1080/14728222.2026.2738183","pmid":"42766349","publication_date":"2026-09-28","importer_version":"2.1.3","text_redistributed":false}},{"id":5942,"title":"An Open-Label, Dose-Escalation Trial of Psilocybin-Assisted Therapy for Bipolar II Depression.","authors":"Downey AE, Szigeti B, Bradley ER, Fernandes-Osterhold G, Sakai K, Llerena K, Fredenburg L, Nerayo J, Evans-Riera L, Nielsen B, Krystal AD, O'Donovan A, Gard DE, Woolley JD.","journal":"The Journal of clinical psychiatry","publication_date":"2026-09-21","publication_year":2026,"doi":"10.4088/jcp.25m16227","pubmed_id":"42765891","openalex_id":"https://openalex.org/W7213540649","source_url":"https://doi.org/10.4088/jcp.25m16227","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Headache / Migraine,Safety,Adverse Events","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-19 01:20:18","last_checked":"2026-09-28 01:20:25","bibtex":null,"source_record_id":"PMID:42765891","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.4088/jcp.25m16227","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42765891","source_url":"https://doi.org/10.4088/jcp.25m16227","doi":"10.4088/jcp.25m16227","pmid":"42765891","publication_date":"2026-09-21","importer_version":"2.1.3","text_redistributed":false}},{"id":5925,"title":"[The use of psychedelics in psychiatry].","authors":"Kéri S.","journal":"Orvosi hetilap","publication_date":"2026-09-13","publication_year":2026,"doi":"10.1556/650.2026.33665","pubmed_id":"42732542","openalex_id":"https://openalex.org/W7212938307","source_url":"https://doi.org/10.1556/650.2026.33665","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Aging,Randomized Controlled Trial,Treatment-Resistant Depression,Safety","study_type":"Randomized Controlled Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-14 01:20:05","last_checked":"2026-09-20 01:20:21","bibtex":null,"source_record_id":"PMID:42732542","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1556/650.2026.33665","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42732542","source_url":"https://doi.org/10.1556/650.2026.33665","doi":"10.1556/650.2026.33665","pmid":"42732542","publication_date":"2026-09-13","importer_version":"2.1.3","text_redistributed":false}},{"id":5920,"title":"Characterizing Psychedelic-Evoked Familiarity: A Comparative Study with Autobiographical and Déjà Vu Experiences.","authors":"Lawrence DW, Doss MK, O'Connor AR","journal":"Journal of psychoactive drugs","publication_date":"2026-09-11","publication_year":2026,"doi":"10.1080/02791072.2026.2729618","pubmed_id":"42725633","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/42725633/","substance_tags":"psilocybin","topic_tags":"Anxiety,Emotional Processing,Observational Study","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-09-12 01:20:05","last_checked":"2026-09-18 01:20:08","bibtex":null,"source_record_id":"PMID:42725633","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42725633/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42725633","source_url":"https://pubmed.ncbi.nlm.nih.gov/42725633/","doi":"10.1080/02791072.2026.2729618","pmid":"42725633","publication_date":"2026-09-11","importer_version":"2.1.3","text_redistributed":false}},{"id":5912,"title":"HORMONAL MODULATION OF PSILOCYBIN RESPONSIVITY ACROSS THE FEMALE REPRODUCTIVE LIFESPAN","authors":"Katarzyna Pawłucka, Aleksandra Pawlucka, Joanna Kadłuczka, Makary Hejduk, Magdalena Grzymek, Justyna Bury, Katarzyna Kraska, Jan Potoniec, Weronika Kępa, Aneta Sobek, Martyna Więcławek","journal":"International Journal of Innovative Technologies in Social Science","publication_date":"2026-08-31","publication_year":2026,"doi":"10.31435/ijitss.3(51).2026.6195","pubmed_id":null,"openalex_id":"https://openalex.org/W7208821196","source_url":"https://doi.org/10.31435/ijitss.3(51).2026.6195","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Anxiety,Chronic Pain,Pharmacology,Mechanism of Action,Receptor Pharmacology,Longevity,Microdosing,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Cancer Patients,Toxicity","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-09-07 01:21:00","last_checked":"2026-09-07 01:21:00","bibtex":null,"source_record_id":"DOI:10.31435/ijitss.3(51).2026.6195","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.31435/ijitss.3(51).2026.6195","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.31435/ijitss.3(51).2026.6195","source_url":"https://doi.org/10.31435/ijitss.3(51).2026.6195","doi":"10.31435/ijitss.3(51).2026.6195","pmid":"","publication_date":"2026-08-31","importer_version":"2.1.3","text_redistributed":false}},{"id":5909,"title":"Psilocybin, From Ancestral Use to Therapeutic Potential: A Multidimensional Review of Its Pharmacological Basis and Current Perspectives.","authors":"Vásquez-Bonilla JN.","journal":"Human psychopharmacology","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1002/hup.70063","pubmed_id":"42693701","openalex_id":"https://openalex.org/W7208787084","source_url":"https://doi.org/10.1002/hup.70063","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Anxiety,Addiction,Chronic Pain,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Microdosing,Review Article,Case Report,Animal Study,Safety,Drug Interactions,Inflammation,Immune Function","study_type":"Clinical Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-05 01:20:06","last_checked":"2026-09-08 01:20:16","bibtex":null,"source_record_id":"PMID:42693701","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1002/hup.70063","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42693701","source_url":"https://doi.org/10.1002/hup.70063","doi":"10.1002/hup.70063","pmid":"42693701","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5902,"title":"Through the Looking-Glass: A Scoping Review of Psychological Mechanisms of Psychedelic-Assisted Therapy for Substance Use Disorders","authors":"Kathryn Fletcher, Jack Freestone, Nadine Ezard, Elizabeth Knock, Krista J. Siefried","journal":"Current Addiction Reports","publication_date":"2026-09-02","publication_year":2026,"doi":"10.1007/s40429-026-00783-7","pubmed_id":null,"openalex_id":"https://openalex.org/W7204988578","source_url":"https://doi.org/10.1007/s40429-026-00783-7","substance_tags":"psilocybin","topic_tags":"Anxiety,Addiction,Mechanism of Action,Emotional Processing,Mystical Experience,Randomized Controlled Trial,Review Article,Observational Study,Toxicity","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-09-03 01:20:15","last_checked":"2026-09-09 01:20:58","bibtex":null,"source_record_id":"DOI:10.1007/s40429-026-00783-7","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1007/s40429-026-00783-7","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1007/s40429-026-00783-7","source_url":"https://doi.org/10.1007/s40429-026-00783-7","doi":"10.1007/s40429-026-00783-7","pmid":"","publication_date":"2026-09-02","importer_version":"2.1.3","text_redistributed":false}},{"id":5898,"title":"Differential effects of psilocybin derivatives on fentanyl-induced conditioned place preference in male and female mice.","authors":"Lovell TN, James PB, Hodgins SL, Johnson Noya S, Arner P, Bobadilla AC.","journal":"Journal of psychopharmacology (Oxford, England)","publication_date":"2026-08-30","publication_year":2026,"doi":"10.1177/02698811261478613","pubmed_id":"42670231","openalex_id":"https://openalex.org/W7204852149","source_url":"https://doi.org/10.1177/02698811261478613","substance_tags":"psilocybin,psilocin","topic_tags":"Anxiety,Addiction,Animal Study,Adverse Events","study_type":"Animal Study","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-01 01:20:07","last_checked":"2026-09-06 01:20:16","bibtex":null,"source_record_id":"PMID:42670231","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1177/02698811261478613","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42670231","source_url":"https://doi.org/10.1177/02698811261478613","doi":"10.1177/02698811261478613","pmid":"42670231","publication_date":"2026-08-30","importer_version":"2.1.3","text_redistributed":false}},{"id":5893,"title":"Psilocybin-Assisted Psychotherapy for Posttraumatic Stress Disorder in Military Veterans: A Pilot Feasibility Study","authors":"ARQ National Psychotrauma Centre","journal":"ClinicalTrials.gov","publication_date":"2026-08-28","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07792538","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,End-of-Life Distress,Neuroplasticity,Mechanism of Action,Emotional Processing,Psychological Flexibility,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Veterans,Safety","study_type":"Randomized Controlled Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-08-29 01:31:17","last_checked":"2026-09-04 01:26:15","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07792538","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07792538","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07792538","source_url":"https://clinicaltrials.gov/study/NCT07792538","doi":"","pmid":"","publication_date":"2026-08-28","importer_version":"2.1.3","text_redistributed":false}},{"id":5879,"title":"Adverse Effect-Related Language in Recreational Psychedelic and non-Psychedelic Substance Experience Reports.","authors":"Hase A, Erdmann M, Calder A, Limbach V, Erowid E, Erowid F, Hasler G.","journal":"Journal of studies on alcohol and drugs","publication_date":"2026-08-22","publication_year":2026,"doi":"10.15288/jsad.25-00426","pubmed_id":"42631663","openalex_id":"https://openalex.org/W7204005858","source_url":"https://doi.org/10.15288/jsad.25-00426","substance_tags":"psilocybin","topic_tags":"Anxiety,Observational Study","study_type":"Observational Study","source_name":"Europe PMC","publication_status":"published","date_added":"2026-08-24 01:20:04","last_checked":"2026-08-29 01:21:13","bibtex":null,"source_record_id":"PMID:42631663","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.15288/jsad.25-00426","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42631663","source_url":"https://doi.org/10.15288/jsad.25-00426","doi":"10.15288/jsad.25-00426","pmid":"42631663","publication_date":"2026-08-22","importer_version":"2.1.3","text_redistributed":false}},{"id":5878,"title":"Psilocybin lengthens hippocampal sharp wave ripples","authors":"Bozkir, I. K.; Lashin, R.; Liu, T.; Pal, D.; Diba, K.; Kinsky, N. R.","journal":"bioRxiv","publication_date":"2026-08-20","publication_year":2026,"doi":"10.64898/2026.08.17.745042","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.08.17.745042","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Neuroplasticity,Receptor Pharmacology","study_type":"Other","source_name":"bioRxiv","publication_status":"preprint","date_added":"2026-08-23 01:20:15","last_checked":"2026-08-27 01:24:39","bibtex":null,"source_record_id":"DOI:10.64898/2026.08.17.745042","abstract_available":true,"abstract_source":"bioRxiv","abstract_source_url":"https://doi.org/10.64898/2026.08.17.745042","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"bioRxiv","source_record_id":"DOI:10.64898/2026.08.17.745042","source_url":"https://doi.org/10.64898/2026.08.17.745042","doi":"10.64898/2026.08.17.745042","pmid":"","publication_date":"2026-08-20","importer_version":"2.1.3","text_redistributed":false}},{"id":5877,"title":"The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A Narrative Review","authors":"Clark Rachel N","journal":"Lynchburg Journal of Medical Science","publication_date":"2026-08-20","publication_year":2026,"doi":"10.63932/3067-7106.1087","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.63932/3067-7106.1087","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Safety","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-08-22 01:20:15","last_checked":"2026-08-24 01:20:13","bibtex":null,"source_record_id":"DOI:10.63932/3067-7106.1087","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.63932/3067-7106.1087","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.63932/3067-7106.1087","source_url":"https://doi.org/10.63932/3067-7106.1087","doi":"10.63932/3067-7106.1087","pmid":"","publication_date":"2026-08-20","importer_version":"2.1.3","text_redistributed":false}}],"total":905,"page":1,"per_page":20,"pages":46,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":"Anxiety","study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":null,"from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}